A randomized, double-blinded, placebo-controlled, dose-escalation phase 1 clinical trial to evaluate the safety and immunogenicity of recombinant HIV-1 envelope protein BG505 SOSIP.GT1.1 gp140 Vaccine, Adjuvanted in healthy, HIV-uninfected adults

  • STATUS
    Recruiting
Updated on 6 April 2021

Summary

Researchers at The Rockefeller University are testing the safety of an investigational vaccine directed against HIV.

Description

The purpose of this study is to find out if the study vaccine is safe and how the immune system responds to it. 

In addition, we hope to learn what kinds of side effects may be caused by the study vaccine, and how severe those side effects will be. This means that volunteers may experience the side effects listed in the risks section of the consent form for this protocol, or others that are not yet known.

Other HIV study products are being tested worldwide. At present, there is no licensed antibody-based product, injectable drug or vaccine to prevent HIV infection, but there are drug products taken by mouth that can be used to reduce the risk of HIV infection (pre-exposure prophylaxis, or PrEP).

Details
Condition *Healthy Patient Studies, *Healthy Volunteers
Clinical Study IdentifierTX270577
Last Modified on6 April 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Between the ages of 18 and 50
In good general health
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note